2Aliev G, Seyidlova D, Lamb BT, et al. Mitochondria and vascular lesions as a central target for thedevelopment of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice[J]. Neurol Res, 2003, 25 (6) :665-674.
5Neissman JI, Wong D, Buttini M, et al. Derivation of polyripotent stem cells from cultured human primo rdial germ cells [ J ]. Science, 2000, 287 (15) :1442.
4Iwakuma M,Anzai T,Kobayashi S,et al.Antisense in vivo knockdowm of synaptotagmin I and synapsin I by HVJ-liposome mediated gene transfer modulates ischemic injury of hippocampus in opposing ways.Neurosci Res2003;45(3):285-96.
5Hilfiker S,Pierbone VA,Czzerinik AJ,et al.Synapsins as regulators of neurotransmitter release.Philos Trans R Soc Lond B Biol Sci 1999;354(1381):269-79.
6Roman GC.Vascular dementia may be the most common form of dementia in the elderly.J Neurol Sci 2002;203-204(15):7-10.
8Masliah E.Recent advances in the understanding of the role of synaptic proteins in Alzheimer's Disease and other neurodegenerative disorders.J Alzheimer's Disease 2001:3:121-9.
9Kovalenko TM,Osadchenko IO,Smozhanyk KH,et al.Structural orgamization of CA1 zone in the hippocampus of rats in the experimental brain ischemia.Fiziol ZH 2004:50(2):86-93.
10Martone ME,jones YZ,Young SJ et al.Modification of postsynaptic densities after transient cerebral ischemia:a quantitative and three-dimensional ultrastructural study.J Neurosci 1999;19(6):1988-97.
7Orsi A,Howson P A,Dixon K.PYM50028,A novel orally active nonpeptide neurotrophic factor inducer,prevents and reverses neuronal damage induced by MPP(+)in mesencephalic neurons and by MPTP in a mouse of Parkinson's disease Visanji NP[J].Rees DD FASEB Journal,2008,22(7):2488-2497.
8Louis F,Robert P,Jacobsen.Sarasapogenin I An investigation of the side chain[J].J.Am.Chem.Soc.,1938,60:28-33.
9Marker R,Wagner B,Ulshafer P R.Steroidal sapogenins[J].J.Am.Chem.Soc.,1947,69:2167-2230.
10Sharma S C,Sati O P,Chand R.Steroidal sapanins of asparagus curillus[J].Phytochemistry(Elsevier),1982,7:1711-1714.
